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Abstract
Introduction: The aim of the study was to describe potential shared risk factors for
incident asthma and COPD in a population-based, 9-year follow-up study.
Methods: From a cohort of 1191 individuals, aged 20-44, who participated in base-
line survey including spirometry, bronchial challenge, and skin prick test (SPT) 742
subjects (62%) were reexamined at follow-up in 2012-2014.
Results: A total of 27 incident cases of asthma and 22 cases of COPD were identi-
fied at follow-up corresponding to an incidence rate of 5.8 (95% CI 3.9-8.4) and 3.5
(2.2-5.3) per 1000 person years, respectively. Among the identified COPD cases a
total of 12 were Asthma-COPD Overlap Syndrome (ACOS). Atopy defined by posi-
tive SPT was a risk factor for asthma in males (OR 7.54; 95% CI 1.24-45.90),
whereas risk factors in females were nasal allergy (3.81; 1.20-12.11), FEV1<100%
predicted (3.96; 1.07-14.62) and parental asthma (3.06; 1.00-9.40). Risk factors for
COPD in males were bronchial hyperresponsiveness (23.13; 1.41-380.50) and
FEV1<100% predicted (all male cases had FEV1<100% predicted) and in females
current smoking (3.34; 1.16-9.59) and asthma at baseline (5.21; 1.48-18.34).
Conclusions: No shared risk factors for incident asthma and COPD were found.
Despite low power when stratifying by sex risk factors for incident asthma and
COPD emphasize considerable gender differences.
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1 | INTRODUCTION
Asthma and COPD are frequent inflammatory obstructive
lung diseases with immense impact on individual health and
public resources.
The prevalence of adult asthma in Denmark is estimated
to 6%-8%.1,2 In the RHINE study the crude incidence rate of
asthma was 2.2 per 1000 person years with higher incidence
in females than males.3
Incidence and prevalence of COPD vary widely depend-
ing on definitions and methods used, diagnostic criteria and
populations studied. The prevalence of COPD in Denmark is
estimated to 8%4 and 15% in persons older than 40 years.5
Asthma and COPD have a considerable functional and
pathological overlap and share symptoms and features
including airway inflammation, airway obstruction, and
bronchial hyperresponsiveness (BHR). More than 20%
actually show components of both diseases having asthma-
COPD overlap syndrome (ACOS).6,7 The overlap syndrome
is supported by the Dutch Hypothesis, which states that
asthma and COPD are different expressions of a single air-
way disease.8 In contrast the British Hypothesis holds that
asthma and COPD are distinct diseases that develop by
unique mechanisms.
Numerous risk factors are described for adult-onset
asthma such as prior respiratory infections, occupational
exposures, hormonal factors, smoking, Atopy, BMI, and
exposure to mould.9,10 Several studies have shown gender
differences in incidence, prevalence, diagnosis and severity
of asthma,11,12 and also differences in perception and behav-
ior are described.13 The main risk factor for COPD is
tobacco smoking, while age, genes, early respiratory infec-
tions, and previous asthma also contribute. In the European
Community Respiratory Health Survey (ECRHS) examining
young adults, tobacco smoking was still the main risk factor,
while BHR, a family history of asthma, and respiratory infec-
tions in childhood were other important determinants.14
Among environmental determinants occupational exposures
to dust and smoke are well-known risk factors.15
The aim of this study was to describe risk factors for
incident asthma and COPD to elucidate shared determinants
for the two diseases in line with the Dutch Hypothesis.
2 | METHODS
This multicentre study was a 9-year follow-up study of 742
individuals and based on the protocol of ECRHS II.16 The
baseline study population was a random sample of 10 000
individuals, aged 20-44 years and standardized by sex and
age. The baseline study consisted of a screening questionnaire
(Phase 1), which was answered by a total of 7271 individuals
(73%) plus interview and clinical examination (Phase 2) of a
random sample corresponding to 20% of the study popula-
tion, a complementary symptom group of individuals report-
ing respiratory symptoms in the screening questionnaire and
a subsample of non-symptomatic individuals comprising a
case-enriched population of 1191 subjects.17
A total of 449 individuals were lost prior to the final
analyses (Figure 1).
The follow-up survey consisted of an interview question-
naire and clinical examination (2012-2014).
The study was approved by The Regional Scientific
Ethical Committees for Southern Denmark and written
informed consent was obtained from all participants.
2.1 | Interview
The interview at baseline and follow-up was a slightly modi-
fied ECRHS II main questionnaire.16
2.2 | Clinical examination
The clinical examination at baseline has been reported
elsewhere.18 In brief, the examination included spirometry
followed by methacholine challenge test alternatively bron-
chodilation (if FEV1 was <70% of predicted or <1.5 L), and
skin prick test (SPT). The SPT comprised a panel of 13
FIGURE 1 Flow chart of participants in clinical examination from
baseline to follow-up
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commercially available inhalation allergens from ALK-
Abello, Gentofte, Denmark.
In the follow-up examination lung function testing by
spirometry and bronchodilation by inhalation of SABA (Sal-
butamol, 200 mg) from spacer (AeroChamber Plus Flow-
Vu), was carried out using an EasyOne Spirometer (ndd
Medical Technologies, Andover, Massachusetts).
2.3 | Definitions
Asthma at baseline was defined by an affirmative answer to
the question “Have you ever had asthma?” combined with
reporting asthma-like symptoms, use of medication or airflow
obstruction at baseline according to a modified definition
used by de Marco et al. in a recent study19 (Supporting Infor-
mation Table S1). Obstruction was defined according to the
lower limit of normal (LLN) i.e. the 5th percentile of FEV1/
FVC distribution corresponding to a z-score <21.64. At
baseline the maximum values of FEV1 and FVC were applied
as methacholine challenge test was performed, whereas at
follow-up the maximum value was the best of either the pre-
or post-bronchodilator value. COPD was defined according to
criteria of LLN combined with symptoms consistent with
COPD, modified from de Marco et al.19 (Supporting Informa-
tion Table S1). Transient airflow obstruction was defined by
obstruction at baseline but no obstruction at follow-up, while
fixed obstruction was defined by having post-bronchodilator
obstruction at follow-up. Incident cases of asthma and COPD
during the follow-up-period were identified by applying defi-
nitions used at baseline, although slightly modified since
BHR was not measured at follow-up (Supporting Information
Table S1). ACOS was defined when criteria for both asthma
and for COPD were met.
BHR at baseline was defined as a drop of 20% or more
in FEV1 associated with a dose of methacholine of 1 mg or
less. The bronchodilation was positive with an increase in
FEV1 of 12% and 200 ml. Atopy was defined by one or
more positive SPT (mean wheal diameter 3 mm). FEV1 as
a potential risk factor was defined by a FEV1 less than 100%
of the predicted corresponding to a z-score <0.20 Current
smokers were defined as individuals, who reported smoking
for at least 1 year and were still smoking.
Occupation at baseline, reported as the last held job, was
coded according to ISCO88. Each code was categorized in
occupations potentially having high or low risk of asthma
and COPD, respectively, using job grouping tools formerly
applied in the ECRHS.21
2.4 | Statistical analyses
Univariate analyses were conducted for each potential risk
factor with the outcome incident asthma, alternatively COPD
calculating odds ratios. Next, data were analyzed by logistic
regression mutually adjusting for the major factors associated
with the outcomes. Results were considered significant using
a five percent level of significance.
Analyses were carried out using Stata, version 13.1 (Sta-
taCorp, College Station, Texas).
3 | RESULTS
Among the 742 individuals, participating in both the baseline
and follow-up survey, individuals with asthma (n5 239) and
COPD (n5 55) at baseline were excluded, leaving a popula-
tion at risk of asthma comprising 503 individuals and a pop-
ulation at risk of COPD of 687 individuals.
Withdrawal analyses of the 449 non-responders showed
that the proportion of cases of asthma and COPD at baseline
did not differ between participants and non-responders
(asthma: 32.2% vs. 27.8%, P5 .120; COPD: 7.4% vs. 6.5%,
P5 .561). Compared with non-responders a larger propor-
tion of the participants were older than 35 years old (53.6%
vs. 41.4%; P5 .000) and reported nasal allergy (42.1% vs.
32.3%; P5 .001) whereas a smaller proportion were female
(53.6% vs. 60.6%; P5 .022) and current smoker (27.0% vs.
33.0%; P5 .030). Participants and non-responders did not
differ significantly concerning the other variables analyzed.
A total of 27 incident cases of asthma and 22 cases of
COPD were identified at follow-up corresponding to a cumu-
lative incidence proportion of 5.4% (95% confidence interval
(CI) 3.4-7.4%) and 3.2% (1.9-4.5%), respectively. Median
length of follow-up was 9.2 years (range 7.0-10.8). The inci-
dence rates were 5.8 per 1000 person years (95% CI 3.9-8.4)
for asthma and 3.5 per 1000 person years (2.2-5.3) for
COPD. A total of 29 cases of ACOS were identified at fol-
low-up: 16 had already ACOS at baseline and of the remain-
ing 13 incident cases 12 had asthma and one had COPD at
baseline leaving no incident cases of ACOS without a diag-
nosis of respiratory disease at baseline.
Characteristics of the population at risk by diagnosis at
follow-up are shown in Table 1 and univariate OR for risk
factors are shown in Figure 2. Nasal allergy constituted a
risk factor for incident asthma (Figure 2; Supporting Infor-
mation Table S2). BHR, FEV1<100% predicted, current
smoking, and having asthma at baseline were all risk factors
for COPD.
The final multivariate model for incident asthma showed
nasal allergy to be an overall risk factor (Table 2). When
stratified by sex Atopy was a risk factor in males and nasal
allergy, FEV1<100% predicted, and parental asthma were all
risk factors in females.
The final multivariate model for incident COPD (Table 3)
) showed that current smoking, asthma at baseline and
FEV1<100% predicted were all risk factors. Stratified by sex
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TABLE 1 Characteristics of the population at risk and associations between determinants at baseline and incident asthma and COPD
Population at
risk, asthma Incident asthma
Population
at risk, COPD Incident COPD
n5 503 (%) n 527 (%) P, Fisher’s exact n5 687 (%) n 52 2 (%) P, Fisher’s exact
Sex, female 248 (49.3) 17 (63.0) .168 371 (54.0) 16 (72.7) .084
Age 35 y 276 (54.9) 12 (44.4) .321 370 (53.9) 15 (68.2) .197
Bronchial hyperresponsiveness 16 (3.2) 2 (7.4) .210 87 (12.7) 10 (45.5) .000
Atopy 141 (28.0) 12 (44.4) .075 262 (38.1) 11 (50.0) .269
FEV1<100% predicted 310 (61.6) 19 (70.4) .418 448 (65.2) 21 (95.5) .001
BMI> 30 kg*m22 64 (12.7) 4 (14.8) .765 105 (15.3) 1 (4.6) .229
Nasal allergy 144 (28.6) 15 (55.6) .003 274 (39.9) 13 (59.1) .076
Parental asthma 74 (14.7) 7 (25.9) .097 148 (21.5) 8 (36.4) .110
Current smoking 132 (26.2) 7 (25.9) 1.000 175 (25.5) 12 (54.6) .004
High-risk occupation (asthma)a 268 (53.8) 12 (44.4) .329 363 (53.3) 13 (59.1) .667
High-risk occupation (COPD)b 281 (56.4) 14 (51.9) .692 383 (56.2) 14 (63.6) .520
Respiratory infection <5 y of age 28 (5.6) 0 (0.0) .388 48 (7.0) 2 (9.1) .662
Mould inside the home 119 (23.7) 5 (18.5) .645 181 (26.4) 7 (31.8) .623
Asthma baseline 193 (28.1) 16 (72.7) .000
aN5 498 (asthma); 5 participants had missing in variable “high risk occupation.”
bN5 681 (COPD); 6 participants had missing in variable “high risk occupation.”
Bold values denote significant associations (P< .05).
FIGURE 2 Risk factors for incident asthma and COPD during follow-up by univariate analyses. The figure shows odds ratios (OR) with 95% confi-
dence intervals (95%CI)
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BHR and FEV1<100% predicted showed significance in
males, whereas current smoking and asthma at baseline were
risk factors in females. In males the OR of current smoking
was high as in females but not significant due to the low
number of male cases.
Stratification by Atopy showed that the proportion of
females in non-atopics was higher than in atopics (86.7% vs.
33.3%; P5 .007). Risk factors for non-atopic asthma were
female sex (OR 6.33; 95% CI 1.33-30.08), FEV1<100% pre-
dicted (12.00; 1.49-96.98), nasal allergy (3.88; 1.17-12.91),
and parental asthma (5.07; 1.60-16.06), while none of the
risk factors in the final analysis showed significant associa-
tion with incident atopic asthma.
Analyses of COPD stratified by Atopy revealed current
smoking to be a risk factor in non-atopic participants (OR
6.16; 95% CI 1.51-25.11) whereas asthma at baseline (9.22;
1.05-81.22) and FEV1<100% predicted (OR not applicable
as all 11 cases with Atopy had FEV1<100% predicted) were
risk factors in COPD for atopic participants. Female sex was
correlated to COPD in non-atopics (6.24; 95% CI 0.76-
51.41).
Analysis of incident asthma by smoking status showed
similar pattern for risk factors in both groups except BHR
since none of the incident cases of asthma who were current
smokers (n5 7) had BHR at baseline.
The proportion of current smokers was higher among
incident cases of COPD compared with the population at
risk (54.6% vs. 24.5%; P5 .004) but 10 of the 22 incident
cases (45%) were not current smokers and 7 of the 10 being
never-smokers. Analyses of COPD by smoking status
showed that considering the remaining risk factors only
having asthma at baseline stood out since all non-smokers
had asthma at baseline (100% vs. 50%; P5 .015). Former
smokers had no increased risk of COPD compared with non-
smokers.
The majority of non-smoking COPD incident cases were
actually ACOS at follow-up (i.e. asthma at baseline and
ACOS at follow-up) according to the diagnostic criterion of
ACOS in this study having diagnosis of both asthma and
COPD, whereas the minor part of smokers were ACOS
(66.7% vs. 33.3%; P5 .043).
Initial analyses of the 13 incident cases of ACOS showed
no significant association with selected risk factors (data not
shown) and no further analyses were performed due to the
few cases. Sensitivity analyses defining asthma solely by an
affirmative answer of the participant to the question “Have
TABLE 2 Risk factors for incident asthma by multivariate analyses; all variables mutually adjusted
Total (n5 27/503) Male (n5 10/255) Female (n5 17/248)
Sex, female 1.82 (0.79-4.18)
Bronchial hyperresponsiveness 2.02 (0.40-10.17) 4.93 (0.40-60.87) 1.32 (0.15-11.92)
Atopy 1.31 (0.50-3.47) 7.54 (1.24-45.90) 0.53 (0.13-2.09)
FEV1<100% predicted 1.55 (0.65-3.71) 0.40 (0.10-1.53) 3.96 (1.07-14.62)
Nasal allergy 2.84 (1.11-7.27) 1.52 (0.34-6.93) 3.81 (1.20-12.11)
Parental asthma 2.13 (0.84-5.41) 0.92 (0.11-8.01) 3.06 (1.00-9.40)
The table shows odds ratios (OR) with 95% confidence intervals (95% CI).
Bold values denote significant associations (P< .05).
TABLE 3 Risk factors for incident COPD by multivariate analyses; all variables mutually adjusted
Total (n5 22/687) Male (n5 6/316) Female (n5 16/371)
Sex, female 1.80 (0.66-4.90)
Bronchial hyperresponsiveness 2.10 (0.77-5.74) 23.13 (1.41-380.50) 1.18 (0.37-3.77)
FEV1<100% predicted 9.32 (1.22-71.35) NA 7.11 (0.91-55.63)
Current smoking 3.83 (1.56-9.42) 5.86 (0.90-38.30) 3.34 (1.16-9.59)
Asthma baseline 4.44 (1.50-13.13) 0.95 (0.06-15.82) 5.21 (1.48-18.34)
Abbreviation: NA, not applicable.
The table shows odds ratios (OR) with 95% confidence intervals (95% CI).
All male cases had FEV1 less than 100% predicted.
Bold values denote significant associations (P< .05).
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you ever had asthma” and COPD solely by airway obstruc-
tion resulted in a slight increase in the number of incident
cases. However, it did not alter the pattern of risk factors
when stratifying by sex (Supporting Information Tables S3
and S4).
4 | DISCUSSION
This study showed that reported nasal allergy at baseline was
a risk factor for incident asthma and current smoking, asthma
at baseline and FEV1<100% predicted were risk factors for
COPD. When stratified by sex the results showed gender dif-
ferences as well as analyses by Atopy differentiated results.
We identified 27 cases of incident asthma and 22 cases of
COPD corresponding to incidence rates of 5.8 and 3.5 per
1000 person-years, respectively, implying that the onset of
both diseases in young adults is quite common.
Incidence rates for asthma in this study were comparable
with the ECRHS (4.5)9 but higher than in the RHINE-study
(2.2)3 with reservations for modified diagnostic criteria.
Regarding COPD our incidence rate of 3.5 was higher
than in ECRHS (1.9) when using comparable criteria.14 This
may be due to the fact that most of the incident cases of
COPD in our study in fact were ACOS i.e. they had asthma
at baseline and met the criteria for both asthma and COPD at
follow-up. Thus, the higher incidence rate of COPD in this
study compared with ECRHS may in addition to the identi-
fied risk factors represent cases of severe asthma classified
as COPD as well due to shared symptoms and incomplete
reversibility.
In this study females had a higher risk than males of
both asthma and COPD. Even though stratification
decreased the power it affected the outcome of the other
determinants significantly. Previous studies have found
increased risk of asthma in females,9,22 especially non-
allergic asthma,23 and that sex hormones may play a major
role in the difference between males and females, but the
mechanism is unclear.24,25
Self-reported nasal allergy was an overall risk factor for
incident asthma. When stratified by sex, however, only in
females. In males, but not females, Atopy was a risk factor,
although these results must be interpreted with caution due
to the few incident cases. Previous studies have shown that
risk factors for adult-onset asthma include female sex, Atopy
and nasal allergy, despite that the majority of incident cases
are seen in non-sensitized individuals.9 Leynaert et al.
showed a higher incidence of asthma in females than in
males and that more females than males with incident asthma
were non-atopic.23 A recent study supported that the female
predominance is more pronounced in non-sensitized individ-
uals.12 This is consistent with our findings, where males with
asthma were sensitized to a greater extent than females. In
contrast, in females nasal allergy was a risk factor, which
may be due to a gender difference in experiencing and
reporting symptoms, or that symptoms of nasal allergy are a
precursor of sensitization. For COPD neither Atopy nor nasal
allergy was a risk factor.
Further analysis of incident asthma by atopic status
revealed distinct differences showing that in non-atopic indi-
viduals the determinants female sex, FEV1<100% predicted,
nasal allergy and parental asthma had elevated OR, which
was not the case in atopic individuals implying that Atopy
plays a minor role in the development of incident asthma in
young adults or that other determinants play a role in atopics.
Concerning COPD the pattern of risk factors were overall
less affected by atopic status except regarding female sex
which also in this group is associated with non-atopic
individuals.
It is suggested from previous studies that reduced lung
function in childhood or adolescence is associated with an
increased risk of asthma in adulthood.26,27 In this study
FEV1 less than 100% of predicted at baseline was a risk
factor for asthma in females, but not in males. This could
be a consequence of gender differences in the dimensions
of airways. FEV1<100% predicted was a risk factor for
COPD both in males and females showing an impact of
even a slightly impaired lung function. A recent study
using FEV1<80% predicted as cut off suggested that low
FEV1 in early adulthood is important in the genesis of
COPD.28 For COPD “childhood disadvantage factors”
have been shown to be associated with FEV1 lower than
predicted and an increased risk of COPD29 being in agree-
ment with this study.
In accordance with previous studies BHR in this study
was positively associated with incident asthma as well as
COPD—significantly for males—in accordance with the
results of ECRHS14 emphasising the impact of BHR in both
diseases.
Parental asthma was associated with incident asthma, but
in the stratified analysis in females only. Previous studies
have shown that a family history of asthma is associated
with a higher risk of incident asthma.9,12
The role of smoking in the development of asthma
remains controversial. In the final model smoking did not
have any association with incident asthma, whereas current
smoking was a risk factor for COPD as expected. Analyses
regarding smoking were reported for current smoking instead
of ever smoking since preceding analyses of both determi-
nants showed that current smoking had a higher impact on
the risk of COPD. Including both current and ever smoking
in the model confirmed these observations. Due to low num-
ber of cases no further analyses of intensity of smoking were
conducted. In non-smokers asthma at baseline was the only
determinant for COPD. A majority of the incident cases of
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COPD in non-smokers had actually ACOS at follow-up i.e.
COPD in addition to a preceding asthma, opposed to the
smokers where the majority had exclusively COPD. This
could lead to considerations if ACOS in line with the obser-
vations of de Marco et al.19 represents a severe form of
asthma, since 92% of incident ACOS in this study have
asthma at baseline and emphasizes the need of consensus
regarding diagnostic criteria for ACOS.
In this study high risk occupation did not show signifi-
cant association with neither asthma nor COPD. The associa-
tion between certain occupational exposures and asthma is
well established21 as well as the association between occupa-
tional exposures and COPD.15 A recent Danish study has
shown occupational exposure to be an essential risk factor
for COPD in never-smokers.30 The negative findings in this
study may be due to the relatively few cases of incident
asthma and COPD resulting in low power or due to a rela-
tively short period of exposure. Alternatively it could express
a healthy worker effect.
4.1 | Strengths and limitations
The present population-based study allows us to describe
risk factors of both asthma and COPD in the same popula-
tion of healthy young adults within an age range where debut
of childhood asthma is a closed chapter and the individuals
are not yet as prone to be affected by comorbid factors as an
older population. In addition, the follow-up study design
eliminates recall bias when using self-reported risk factors at
baseline for analyzing risk factors for the diseases.
However, the relatively low response rate at follow-up
(62%) and the limited number of incident cases of asthma
and COPD leading to low power of the analyses are limita-
tions of the study.
Furthermore, misclassification may occur due to the
choice of diagnostic criteria including the use of self-
reported information e.g. the question of ever asthma and
applying the LLN i.e. the 5th percentile of FEV1/FVC cor-
responding to z-score <21.64 in this healthy study popu-
lation. The applied criteria for asthma and COPD are in
line with recent research.19 However, using ever asthma
plus asthma-like symptoms identifies only individuals with
current asthma which implies a risk of including cases
with relapse of asthma at follow-up but free of symptoms
at baseline. Sensitivity analysis applying only the question
of ever asthma did not alter the pattern of risk factors. The
application of exclusively ever asthma as a diagnostic cri-
terion in turn has a risk of recall bias and all in all this
highlights the challenges with diagnostic criteria. Sensitiv-
ity analyses of COPD by only applying airway obstruction
as diagnostic criterion resulted in an increased number of
incident cases which partially could be due to an additional
inclusion of non-symptomatic individuals with airway
obstruction.
5 | CONCLUSIONS
In this study no shared risk factors for incident asthma and
COPD were found, which is in favor of the British Hypothe-
sis. However, asthma at baseline was a determinant for
COPD at follow-up supporting the Dutch Hypothesis of flu-
ent development from asthma to COPD. Despite the fact that
individuals with ACOS constitute a subgroup in the analyses
of both asthma and COPD, no shared risk factors were found
when analyzing asthma and COPD separately. Risk factors
for both asthma and COPD were gender specific. Altogether
stratification of determinants by sex, Atopy and smoking sta-
tus shows that risk factors for each individual are highly
interdependent and thus the sum of risk factors is prone to a
high individual diversity.
Although our results were only applicable on the young
adults investigated, the results emphasized the need for early
identification of young adults at risk for the obstructive lung
diseases, ACOS included. Furthermore, additional investiga-
tions are needed to shed light on gender differences in the
obstructive lung diseases.
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SUPPORTING INFORMATION
Additional Supporting Information may be found online in
the supporting information tab for this article.
Table S1: Diagnostic criteria at baseline and follow-up:
Table S2: The table shows odds ratios (OR) with 95% con-
fidence intervals (95% CI).
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Table S3: Mutually adjusted risk factors (OR; 95%CI) for
incident asthma by multivariate analyses. Sensitivity analy-
sis based on alternative definition of incident asthma (i.e.
no affirmative answer to ‘Have you ever had asthma’ at
baseline and affirmative answer at follow-up).
Table S4: Mutually adjusted risk factors (OR; 95%CI) for
incident COPD by multivariate analyses. Sensitivity analy-
sis based on alternative definition of incident COPD (i.e.
no obstruction according to LLN at baseline and fixed
obstruction at follow-up).
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